The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

However, a new discovery by scientists at the Francis Crick Institute may offer a new way to treat this aggressive cancer.

The symptoms of pancreatic cancer can be nonspecific, which means identifying the disease is often a challenge.

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

Some colorectal and pancreatic cancers may be resistant to KRAS G12C inhibitors due to co-occurring genetic alterations, according to a study published in the AACR journal Clinical Cancer Research.

Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...

Feb. 18, 2025 — Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis.

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...